documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
36 rows where docket_id = "FDA-2020-N-0026" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-0026-0036 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Gomekli (mirdametinib) | Notice | Announcement | 2025-03-13T04:00:00Z | 2025 | 3 | 2025-03-13T04:00:00Z | 2025-03-13T12:56:52Z | 2025-04021 | 0 | 0 | 09000064869e6ed4 | |
| FDA-2020-N-0026-0035 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ALHEMO (concizumab-mtci) | Notice | General Notice | 2025-01-15T05:00:00Z | 2025 | 1 | 2025-01-15T14:35:52Z | 2025-00750 | 0 | 0 | 09000064868c0464 | ||
| FDA-2020-N-0026-0034 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; CRENESSITY (crinecerfont) | Notice | Announcement | 2025-01-10T05:00:00Z | 2025 | 1 | 2025-01-10T05:00:00Z | 2025-01-10T13:53:44Z | 2025-00340 | 0 | 0 | 09000064868ade79 | |
| FDA-2020-N-0026-0033 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AQNEURSA (Levacetylleucine) | Notice | Announcement | 2024-10-15T04:00:00Z | 2024 | 10 | 2024-10-15T18:42:22Z | 2024-23712 | 0 | 0 | 09000064867ce892 | ||
| FDA-2020-N-0026-0032 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; MIPLYFFA (Arimoclomol) | Notice | Announcement | 2024-10-15T04:00:00Z | 2024 | 10 | 2024-10-15T18:42:10Z | 2024-23646 | 0 | 0 | 09000064867ce712 | ||
| FDA-2020-N-0026-0031 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LIVMARLI (maralixibat) | Notice | Announcement | 2024-08-28T04:00:00Z | 2024 | 8 | 2024-08-28T04:00:00Z | 2024-08-28T13:55:40Z | 2024-19334 | 0 | 0 | 09000064866b0229 | |
| FDA-2020-N-0026-0030 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; XOLREMDI (mavorixafor) | Notice | Announcement | 2024-05-16T04:00:00Z | 2024 | 5 | 2024-05-16T12:55:40Z | 2024-10715 | 0 | 0 | 0900006486568fbb | ||
| FDA-2020-N-0026-0029 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OJEMDA (tovorafenib) | Notice | Announcement | 2024-05-15T04:00:00Z | 2024 | 5 | 2024-05-15T04:00:00Z | 2024-05-15T13:21:52Z | 2024-10583 | 0 | 0 | 0900006486566994 | |
| FDA-2020-N-0026-0028 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; DUVYZAT (givinostat) | Notice | Announcement | 2024-04-11T04:00:00Z | 2024 | 4 | 2024-04-11T04:00:00Z | 2024-04-11T14:00:15Z | 2024-07657 | 0 | 0 | 09000064864cd930 | |
| FDA-2020-N-0026-0026 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2024-01-11T05:00:00Z | 2024 | 1 | 2024-01-11T05:00:00Z | 2024-01-11T14:57:56Z | 2024-00400 | 0 | 0 | 09000064863921da | |
| FDA-2020-N-0026-0027 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2024-01-11T05:00:00Z | 2024 | 1 | 2024-01-11T05:00:00Z | 2024-01-11T17:10:21Z | 2024-00401 | 0 | 0 | 090000648639237b | |
| FDA-2020-N-0026-0025 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2024-01-09T05:00:00Z | 2024 | 1 | 2024-01-09T05:00:00Z | 2024-01-09T14:08:36Z | 2024-00263 | 0 | 0 | 09000064863887b3 | |
| FDA-2020-N-0026-0024 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2023-12-05T05:00:00Z | 2023 | 12 | 2023-12-05T05:00:00Z | 2023-12-05T17:53:57Z | 2023-26652 | 0 | 0 | 09000064862f4366 | |
| FDA-2020-N-0026-0023 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2023-06-06T04:00:00Z | 2023 | 6 | 2023-06-06T04:00:00Z | 2023-06-06T13:56:37Z | 2023-11907 | 0 | 0 | 0900006485ac482e | |
| FDA-2020-N-0026-0022 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2023-04-24T04:00:00Z | 2023 | 4 | 2023-04-24T04:00:00Z | 2023-04-24T13:13:08Z | 2023-08518 | 0 | 0 | 090000648597a166 | |
| FDA-2020-N-0026-0021 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2023-03-30T04:00:00Z | 2023 | 3 | 2023-03-30T04:00:00Z | 2023-03-30T17:50:15Z | 2023-06593 | 0 | 0 | 090000648588ded3 | |
| FDA-2020-N-0026-0020 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2023-03-16T04:00:00Z | 2023 | 3 | 2023-03-16T04:00:00Z | 2023-03-16T14:40:38Z | 2023-05364 | 0 | 0 | 09000064857b8ed4 | |
| FDA-2020-N-0026-0019 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2023-03-16T04:00:00Z | 2023 | 3 | 2023-03-16T04:00:00Z | 2023-03-16T14:29:35Z | 2023-05355 | 0 | 0 | 09000064857b8f16 | |
| FDA-2020-N-0026-0018 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2022-10-07T04:00:00Z | 2022 | 10 | 2022-10-07T04:00:00Z | 2022-10-07T15:04:36Z | 2022-21865 | 0 | 0 | 09000064853d3898 | |
| FDA-2020-N-0026-0017 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2022-10-07T04:00:00Z | 2022 | 10 | 2022-10-07T04:00:00Z | 2022-10-07T14:34:49Z | 2022-21851 | 0 | 0 | 09000064853d3853 | |
| FDA-2020-N-0026-0016 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2022-08-29T04:00:00Z | 2022 | 8 | 2022-08-29T04:00:00Z | 2022-08-29T19:19:19Z | 2022-18519 | 0 | 0 | 0900006485285365 | |
| FDA-2020-N-0026-0015 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2021-10-27T04:00:00Z | 2021 | 10 | 2021-10-27T04:00:00Z | 2022-08-29T19:17:39Z | 2021-23336 | 0 | 0 | 0900006484dfa50e | |
| FDA-2020-N-0026-0014 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal | Notice | Withdrawal | 2021-10-06T04:00:00Z | 2021 | 10 | 2021-10-06T04:00:00Z | 2022-08-29T19:17:24Z | 2021-21823 | 0 | 0 | 0900006484dbc501 | |
| FDA-2020-N-0026-0013 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2021-09-30T04:00:00Z | 2021 | 9 | 2021-09-30T04:00:00Z | 2022-08-29T19:17:13Z | 2021-21311 | 0 | 0 | 0900006484db3d0f | |
| FDA-2020-N-0026-0012 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2021-07-02T04:00:00Z | 2021 | 7 | 2021-07-02T04:00:00Z | 2022-08-29T19:16:59Z | 2021-14191 | 0 | 0 | 0900006484bcc3e6 | |
| FDA-2020-N-0026-0010 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2021-03-12T05:00:00Z | 2021 | 3 | 2021-03-12T05:00:00Z | 2022-08-29T19:16:27Z | 2021-05208 | 0 | 0 | 0900006484a68d9d | |
| FDA-2020-N-0026-0011 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2021-03-12T05:00:00Z | 2021 | 3 | 2021-03-12T05:00:00Z | 2022-08-29T19:16:45Z | 2021-05207 | 0 | 0 | 0900006484a68e24 | |
| FDA-2020-N-0026-0009 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2021-02-16T05:00:00Z | 2021 | 2 | 2021-02-16T05:00:00Z | 2022-08-29T19:16:13Z | 2021-03012 | 0 | 0 | 0900006484a38031 | |
| FDA-2020-N-0026-0008 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher: Rare Pediatric Disease Product | Notice | General Notice | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2020-12-17T18:16:44Z | 2020-27760 | 0 | 0 | 09000064849a4513 | |
| FDA-2020-N-0026-0007 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2020-12-17T16:38:06Z | 2020-27778 | 0 | 0 | 09000064849a448f | |
| FDA-2020-N-0026-0006 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-12-07T05:00:00Z | 2020 | 12 | 2020-12-07T05:00:00Z | 2020-12-07T16:10:20Z | 2020-26801 | 0 | 0 | 0900006484989f80 | |
| FDA-2020-N-0026-0005 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-09-16T04:00:00Z | 2020 | 9 | 2020-09-16T04:00:00Z | 2020-09-16T13:13:28Z | 2020-20387 | 0 | 0 | 090000648485c8f0 | |
| FDA-2020-N-0026-0004 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-09-15T04:00:00Z | 2020 | 9 | 2020-09-15T04:00:00Z | 2020-09-15T13:29:33Z | 2020-20320 | 0 | 0 | 09000064848591c8 | |
| FDA-2020-N-0026-0003 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-09-04T04:00:00Z | 2020 | 9 | 2020-09-04T04:00:00Z | 2020-09-04T12:54:43Z | 2020-19604 | 0 | 0 | 09000064848446df | |
| FDA-2020-N-0026-0002 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-08-25T04:00:00Z | 2020 | 8 | 2020-08-25T04:00:00Z | 2020-08-25T12:58:38Z | 2020-18648 | 0 | 0 | 090000648481d0d5 | |
| FDA-2020-N-0026-0001 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-01-23T05:00:00Z | 2020 | 1 | 2020-01-23T05:00:00Z | 2020-01-23T13:49:52Z | 2020-01059 | 0 | 0 | 09000064842de5ef |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;